outflow facility
Showing 1 - 25 of 1,153
Glaucoma Trial in Wuerzburg (Pneumatonometry after microshunt implantation, Pneumatonometry after ab interno trabeculectomy)
Completed
- Glaucoma
- Pneumatonometry after microshunt implantation
- Pneumatonometry after ab interno trabeculectomy
-
Wuerzburg, Bavaria, GermanyDepartment of Ophthalmology University Hospital Wuerzburg
Sep 16, 2022
Ocular Hypertension Trial in Rochester (Latanoprostene Bunod, Placebo)
Recruiting
- Ocular Hypertension
- Latanoprostene Bunod
- Placebo
-
Rochester, MinnesotaBausch Site 001
Sep 29, 2022
Primary Open Angle Glaucoma or Ocular Hypertension Trial in Rochester, Durham (Netarsudil Ophthalmic Solution 0.02%, Placebo
Completed
- Primary Open Angle Glaucoma or Ocular Hypertension
- Netarsudil Ophthalmic Solution 0.02%
- Placebo Comparator
-
Rochester, Minnesota
- +1 more
Jul 29, 2019
Open Angle Glaucoma Trial (NCX 470, Placebo)
Not yet recruiting
- Open Angle Glaucoma
- NCX 470
- Placebo
- (no location specified)
Jul 6, 2023
Glaucoma, OHT - Ocular Hypertension Trial in Rochester, Omaha, Columbus (Timolol 0.5% ophthalmic solution, Latanoprost 0.005%
Recruiting
- Glaucoma
- OHT - Ocular Hypertension
- Timolol 0.5% ophthalmic solution
- Latanoprost 0.005% Ophthalmic Solution
-
Rochester, Minnesota
- +2 more
Jul 15, 2022
Venous Stenosis, Venous Occlusion Trial in Athens, Glasgow, Oxford (WRAPSODY Stent Graft Placement)
Completed
- Venous Stenosis
- Venous Occlusion
- WRAPSODY Stent Graft Placement
-
Athens, Greece
- +2 more
Dec 22, 2021
Normal Tension Glaucoma Trial (water drinking test)
Not yet recruiting
- Normal Tension Glaucoma
- water drinking test
- (no location specified)
Sep 29, 2021
Brain Imaging in Cerebral Venous Outflow Disturbance
Recruiting
- Abnormal Cerebral Venous Sinus Morphology
- +2 more
- high-resolution 3D-T1
- +4 more
-
Beijin, XI Cheng District, ChinaXuanwu hospital;Capital Medical University
Apr 14, 2023
Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial (Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match
Not yet recruiting
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
- Aficamten (CK-3773274) (5 mg, 10 mg, 15 mg and 20 mg)
- +3 more
- (no location specified)
Mar 2, 2023
Iliofemoral Venous Obstruction Trial in Worldwide (Abre venous self-expanding stent system)
Completed
- Iliofemoral Venous Obstruction
- Abre venous self-expanding stent system
-
Orange, California
- +23 more
Oct 17, 2022
Depression Trial in Goa (Community Intervention, Healthy Activity Program (HAP))
Not yet recruiting
- Depression
- Community Intervention
- Healthy Activity Program (HAP)
-
Goa, IndiaSangath
May 26, 2023
Neonatal Death Trial in Lira (Intervention arm: An integrated package)
Completed
- Neonatal Death
- +3 more
- Intervention arm: An integrated package
-
Lira, UgandaLira District
Nov 19, 2022
Newborn Morbidity Trial in Karachi (KMC)
Completed
- Newborn Morbidity
- KMC
-
Karachi, Sindh, PakistanAga Khan University
Nov 8, 2023
Heart Defect, Congenital Trial in Worldwide (Xeltis Bioabsorbable Pulmonary Valved Conduit)
Enrolling by invitation
- Heart Defect, Congenital
- Xeltis Bioabsorbable Pulmonary Valved Conduit
-
Los Angeles, California
- +9 more
Jan 24, 2023
Venous Stenosis, Venous Occlusion Trial in Worldwide (Merit WRAPSODY Endovascular Stent Graft, PTA)
Recruiting
- Venous Stenosis
- Venous Occlusion
- Merit WRAPSODY Endovascular Stent Graft
- PTA
-
Tempe, Arizona
- +54 more
Oct 25, 2022
Septic Shock, Resuscitation Trial in Mansoura, Cairo (Group VTI, Group IVC)
Recruiting
- Septic Shock
- Resuscitation
- Group VTI
- Group IVC
-
Mansoura, Dakahlia, Egypt
- +1 more
Nov 9, 2023
Solid Tumors and Metastatic Lesions Trial in Toronto (Magnetic resonance - guided radiation therapy (MRgRT))
Recruiting
- Solid Tumors and Metastatic Lesions
- Magnetic resonance - guided radiation therapy (MRgRT)
-
Toronto, Ontario, CanadaUniversity Health Network
Oct 6, 2022
Obstructive Hypertrophic Cardiomyopathy (oHCM) Trial in Worldwide (CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg), Placebo to match
Recruiting
- Obstructive Hypertrophic Cardiomyopathy (oHCM)
- CK-3773274 (5 mg, 10 mg, 15 mg and 20 mg)
- Placebo to match CK-3773274
-
Anchorage, Alaska
- +31 more
Aug 9, 2022
COMPASSION XT PAS - Post-approval Study of SAPIEN XT THV in
Active, not recruiting
- Pulmonary Valve Insufficiency
- +5 more
- SAPIEN XT THV
-
Birmingham, Alabama
- +11 more
Oct 24, 2022
Rhopressa on Episcleral and Retinal Blood Flow in Ocular
Completed
- Ocular Hypertension
- Suspect Glaucoma
- Netarsudil ophthalmic solution 0.02% one drop nightly for 1-2 weeks
-
Baltimore, Maryland
- +3 more
Mar 24, 2022
Venous Stenosis, Venous Occlusion, Chronic Renal Failure Trial (Solaris DE, PTA)
Not yet recruiting
- Venous Stenosis
- +2 more
- Solaris DE
- PTA
- (no location specified)
Oct 23, 2023
Hypertrophic Cardiomyopathy, Mechanical Hyper-synchronicity Trial in Bordeaux (Echocardiography (TEE), Magnetic resonance
Completed
- Hypertrophic Cardiomyopathy
- Mechanical Hyper-synchronicity
- Echocardiography (TEE)
- +3 more
-
Bordeaux, FranceCHU de Bordeaux
Feb 8, 2022
Stroke Rehabilitation, Functional Recovery, and
Recruiting
- Stroke
-
Salt Lake City, UtahUniversity of Utah
May 29, 2022
Blood Transfusion Trial (Community-Facility Transfusion Committee (CFTC))
Not yet recruiting
- Blood Transfusion
- Community-Facility Transfusion Committee (CFTC)
- (no location specified)
Nov 15, 2023
Evaluation of a Multi-country Medical Oxygen Program
Not yet recruiting
- Hypoxemia
- +4 more
- Multi-faceted oxygen systems strengthening interventions (different for each country)
-
Melbourne, Victoria, AustraliaMCRI / University of Melbourne
Oct 12, 2023